The role of imaging in radiotherapy for Hodgkin lymphoma

Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

Standard

The role of imaging in radiotherapy for Hodgkin lymphoma. / Hutchings, Martin; Berthelsen, Anne Kiil; Barrington, Sally F.

Radiotherapy for Hodgkin lymphoma. ed. / Lena Specht; Joachim Yahalom. Heidelberg : Springer, 2011. p. 81-89.

Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

Harvard

Hutchings, M, Berthelsen, AK & Barrington, SF 2011, The role of imaging in radiotherapy for Hodgkin lymphoma. in L Specht & J Yahalom (eds), Radiotherapy for Hodgkin lymphoma. Springer, Heidelberg, pp. 81-89. https://doi.org/10.1007/978-3-540-78944-4

APA

Hutchings, M., Berthelsen, A. K., & Barrington, S. F. (2011). The role of imaging in radiotherapy for Hodgkin lymphoma. In L. Specht, & J. Yahalom (Eds.), Radiotherapy for Hodgkin lymphoma (pp. 81-89). Springer. https://doi.org/10.1007/978-3-540-78944-4

Vancouver

Hutchings M, Berthelsen AK, Barrington SF. The role of imaging in radiotherapy for Hodgkin lymphoma. In Specht L, Yahalom J, editors, Radiotherapy for Hodgkin lymphoma. Heidelberg: Springer. 2011. p. 81-89 https://doi.org/10.1007/978-3-540-78944-4

Author

Hutchings, Martin ; Berthelsen, Anne Kiil ; Barrington, Sally F. / The role of imaging in radiotherapy for Hodgkin lymphoma. Radiotherapy for Hodgkin lymphoma. editor / Lena Specht ; Joachim Yahalom. Heidelberg : Springer, 2011. pp. 81-89

Bibtex

@inbook{ada60c6483334103a281d3661f7b6f55,
title = "The role of imaging in radiotherapy for Hodgkin lymphoma",
abstract = "This chapter outlines the increasingly important role of advanced imaging methods in the radiotherapy for Hodgkin lymphoma (HL). CT has become the cornerstone in modern conformal lymphoma radiotherapy. The use of PET/CT before, during and after chemotherapy has an important impact on the selection of early- and advanced-stage patients who receive radiotherapy. PET/CT is more sensitive for HL staging than CT alone, and the method results in upstaging of a significant proportion of patients. Some studies suggest that this may also result in larger radiotherapy volumes. On the other hand, the more precise determination of disease extent can also be used to allow more patient-tailored and less-toxic radiotherapy to the patients. ",
author = "Martin Hutchings and Berthelsen, {Anne Kiil} and Barrington, {Sally F}",
year = "2011",
doi = "10.1007/978-3-540-78944-4",
language = "English",
isbn = "978-3-540-78455-5",
pages = "81--89",
editor = "Lena Specht and Joachim Yahalom",
booktitle = "Radiotherapy for Hodgkin lymphoma",
publisher = "Springer",
address = "Switzerland",

}

RIS

TY - CHAP

T1 - The role of imaging in radiotherapy for Hodgkin lymphoma

AU - Hutchings, Martin

AU - Berthelsen, Anne Kiil

AU - Barrington, Sally F

PY - 2011

Y1 - 2011

N2 - This chapter outlines the increasingly important role of advanced imaging methods in the radiotherapy for Hodgkin lymphoma (HL). CT has become the cornerstone in modern conformal lymphoma radiotherapy. The use of PET/CT before, during and after chemotherapy has an important impact on the selection of early- and advanced-stage patients who receive radiotherapy. PET/CT is more sensitive for HL staging than CT alone, and the method results in upstaging of a significant proportion of patients. Some studies suggest that this may also result in larger radiotherapy volumes. On the other hand, the more precise determination of disease extent can also be used to allow more patient-tailored and less-toxic radiotherapy to the patients.

AB - This chapter outlines the increasingly important role of advanced imaging methods in the radiotherapy for Hodgkin lymphoma (HL). CT has become the cornerstone in modern conformal lymphoma radiotherapy. The use of PET/CT before, during and after chemotherapy has an important impact on the selection of early- and advanced-stage patients who receive radiotherapy. PET/CT is more sensitive for HL staging than CT alone, and the method results in upstaging of a significant proportion of patients. Some studies suggest that this may also result in larger radiotherapy volumes. On the other hand, the more precise determination of disease extent can also be used to allow more patient-tailored and less-toxic radiotherapy to the patients.

U2 - 10.1007/978-3-540-78944-4

DO - 10.1007/978-3-540-78944-4

M3 - Book chapter

SN - 978-3-540-78455-5

SP - 81

EP - 89

BT - Radiotherapy for Hodgkin lymphoma

A2 - Specht, Lena

A2 - Yahalom, Joachim

PB - Springer

CY - Heidelberg

ER -

ID: 34060204